These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A phase II randomized controlled trial to evaluate the safety and efficacy of Praneem polyherbal vaginal tablets compared with betadine vaginal pessary in women with symptoms of abnormal vaginal discharge. Salhan S, Tripathi V, Sehgal R, Kumar G, Talwar GP, Chatterjee A. Asia Pac J Public Health; 2009 Oct; 21(4):461-8. PubMed ID: 19783561 [Abstract] [Full Text] [Related]
47. Safety and tolerability of the new contraceptive sponge Protectaid. Creatsas G, Elsheikh A, Colin P. Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):91-5. PubMed ID: 12201327 [Abstract] [Full Text] [Related]
50. Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study. Joglekar NS, Joshi SN, Navlakha SN, Katti UR, Mehendale SM. Indian J Med Res; 2006 Apr; 123(4):547-52. PubMed ID: 16783046 [Abstract] [Full Text] [Related]
51. Termination of pregnancy in rodents by oral administration of praneem, a purified neem seed extract. Mukherjee S, Talwar GP. Am J Reprod Immunol; 1996 Jan; 35(1):51-6. PubMed ID: 8789560 [Abstract] [Full Text] [Related]
54. Spermicidal Constituents of Ethanolic Extract of Sacoglottis gabonensis Stem Bark. Alade GO, Moody JO, Awotona OR, Adesanya SA, Lai D, Proksch P. Folia Med (Plovdiv); 2017 Dec 20; 59(4):437-442. PubMed ID: 29341951 [Abstract] [Full Text] [Related]
55. Safety studies of sperm agglutinating factor produced by Staphylococcus aureus as a vaginal contraceptive: in vivo studies. Kaur S, Prabha V, Kaur K. Gynecol Endocrinol; 2011 Nov 20; 27(11):956-60. PubMed ID: 21500995 [Abstract] [Full Text] [Related]